Sargent Bickham Lagudis’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-17
Closed 1102
2022
Q3
$0 Sell
17
-194
-92% -$4.04K ﹤0.01% 1163
2022
Q2
$4K Sell
211
-72
-25% -$1.28K ﹤0.01% 843
2022
Q1
$5K Hold
283
﹤0.01% 809
2021
Q4
$6K Hold
283
﹤0.01% 789
2021
Q3
$5K Sell
283
-72
-20% -$1.65K ﹤0.01% 819
2021
Q2
$10K Hold
355
﹤0.01% 719
2021
Q1
$11K Sell
355
-22
-6% -$750 ﹤0.01% 685
2020
Q4
$11K Hold
377
﹤0.01% 652
2020
Q3
$9K Hold
377
﹤0.01% 616
2020
Q2
$7K Sell
377
-349
-48% -$4.59K ﹤0.01% 620
2020
Q1
$6K Buy
726
+342
+89% +$3.91K ﹤0.01% 633
2019
Q4
$5K Sell
384
-299
-44% -$3.62K ﹤0.01% 703
2019
Q3
$8K Sell
683
-11,186
-94% -$207K ﹤0.01% 595
2019
Q2
$290K Sell
11,869
-3,300
-22% -$95.1K 0.03% 177
2019
Q1
$483K Buy
+15,169
New +$538K 0.06% 150

Other funds holding CVET

Sargent Bickham Lagudis's CVET Position: Q4 2022 in Review

Sargent Bickham Lagudis sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 17 shares.

Sargent Bickham Lagudis first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $483K in Q1 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Sargent Bickham Lagudis reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 17 Covetrus, Inc. Common Stock shares in Q4 2022.
  • Sargent Bickham Lagudis first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Sargent Bickham Lagudis's Covetrus, Inc. Common Stock position peaked at $483K in Q1 2019.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.